This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
RETRACTION: Our Experience With Propranolol for Infantile Hemangioma
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVascular Malformations and Hemangiomas · Parvovirus B19 Infection Studies · Vascular Anomalies and Treatments
RETRACTION: Y. Wu, P. Zhao, W. Song, W. Lu, T. Dai, and L. Wang, “Our Experience with Propranolol for Infantile Hemangioma,” Skin Research and Technology 29, no. 4 (2023): e13310, https://doi.org/10.1111/srt.13310.
The above article, published online on 22 April 2023 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; Skin Research and Technology; and John Wiley & Sons Ltd. The article was accepted for publication following an insufficient peer review process that does not meet the standards of the journal's peer review policy. Furthermore, several inconsistencies between data presented in tables and results discussed in the text were identified. Accordingly, the article has been retracted.